Alpha Capital Anstalt v. Intellipharmaceutics International Inc.

Background

Alpha Capital Anstalt sued Intellipharmaceutics International Inc. (IPCI), Isa Odidi, Amina Odidi, and Andrew Patient under Sections 11, 12(a)(2), and 15 of the Securities Act of 1933. Alpha alleged that the defendants failed to disclose in IPCI’s registration statement that Patient intended to leave his position as IPCI’s chief financial officer shortly after the company’s securities offering.

IPCI’s registration statement became effective on October 11, 2018. Alpha purchased more than two million pre-funded units on October 12, 2018, and later purchased additional IPCI shares. Patient notified IPCI in November 2018 that he intended to resign, and IPCI announced his resignation after the market closed on November 5, 2018. IPCI’s stock price fell at the November 6 opening and later declined further. Alpha alleged that the undisclosed information caused its losses.

After discovery, Alpha and the defendants filed cross-motions for summary judgment on liability. Summary judgment is a decision without a trial when the evidence shows that no important factual dispute requires a jury’s decision and one side is entitled to judgment under the law.

Applicable law

Sections 11 and 12(a)(2) can impose liability for material false statements or omissions in a registration statement or prospectus. Section 15 provides liability for certain control persons when there is an underlying violation of Sections 11 or 12(a)(2). The court explained that plaintiffs generally do not need to prove reliance or loss causation as an initial element of Sections 11 and 12(a)(2) claims.

The court also discussed “negative loss causation,” an affirmative defense under which defendants can avoid liability by proving that the alleged misstatement or omission did not cause the investor’s loss. The defendants bear the burden of proving that defense.

Analysis

The defendants relied mainly on an expert report by economist Dr. Sunita Surana. She conducted an event study, a statistical analysis used to examine whether a particular event affected a company’s stock price while accounting for broader market and industry movements. Her analysis found that IPCI’s price decline after the November 5 announcement was not statistically significant and fell within the company’s normal price volatility. She also found no statistically significant price change on any day from November 6 through November 12 or during that period as a whole.

The court rejected Alpha’s argument that the defendants had failed to account for a possible earlier disclosure of Patient’s departure. The defendants presented evidence that the information first reached the market through the November 5 press release, and Alpha offered no evidence supporting an earlier disclosure. The court treated Alpha’s theory as speculation that could not create a genuine factual dispute.

The court also rejected Alpha’s reliance on an expert report by Daniel Bettencourt. The report was unsworn and did not contain the language required for an unsworn statement made under penalty of perjury. The court therefore held that it was inadmissible. The court further stated that, even if the report could be considered, it was speculative, conclusory, and did not conduct its own event study or other analysis. It mainly criticized Dr. Surana’s methodology without adequately supporting its assertions.

The court also disagreed with Bettencourt’s premise that the defendants had to prove that IPCI’s stock traded in an efficient market. The court explained that market efficiency can matter to the fraud-on-the-market theory used to establish reliance in certain fraud claims, but reliance is not an element of Alpha’s Sections 11 and 12(a)(2) claims. The court further distinguished reliance from loss causation.

Disposition

The court held that the defendants had established the negative loss causation defense: the evidence showed that the November 5 announcement concerning Patient’s departure did not cause the stock-price declines on which Alpha based its losses. Because Alpha failed to present admissible evidence creating a genuine factual dispute on that issue, the defendants were entitled to judgment.

The defendants’ motion for summary judgment was granted. Alpha’s motion for summary judgment was denied. The Clerk of Court was directed to enter judgment for the defendants and close the case. The court did not need to decide whether the registration statement contained a material omission because the defendants prevailed on the separate issue of causation.